Sarcoma: open trials in Portugal

• NCT07541170

  A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)

  Trial Treatment · Phase 3 · Hoffmann-La Roche

  Instituto Portugues De Oncologia De Coimbra Francisco Gentil E.P.E., Coimbra · Hospital Cuf Tejo S.A., Lisbon · Champalimaud Clinical Centre, Lisbon · Unidade Local De Saude De Loures-Odivelas EPE, Loures · Unidade Local de Saude de Sao Joao E.P.E., Porto · Unidade Local de Saúde de Gaia/Espinho, E. P. E, Vila Nova de Gaia

  Registry updated 2026-10-13

• 2025-521702-18-00

  A phase I open-label, multi-center study to evaluate the safety, tolerability, dosimetry, and preliminary activity of [177Lu]Lu-DFC413 and safety and imaging properties of [68Ga]Ga-NNS309 in patients with solid tumors

  Trial Treatment · Phase 1 · Novartis Pharma AG

  Instituto Portugues de Oncologia do Porto Francisco Gentil, E.P.E., Porto

  Registry updated 2026-09-15

• NCT06408441

  The Epithelioid Hemangioendothelioma Registry of the European Reference Network on Rare Adult Solid Cancers (EURACAN)

  Research · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

  Instituto Português Oncologia do Porto Francisco Gentil, Porto

  Registry updated 2026-04-03

• NCT04625907

  FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma

  Trial Treatment · Phase 1/2 · University of Birmingham

  Centro Hospitalar Universitario de Coimbra, Coimbra · Instituto Portugues de Oncologia de Lisboa Francisco Gentil, E.P.E., Lisbon · Centro Hospitalar Universitário de São João, Porto · Instituto Portugues de Oncologia do Porto Francisco Gentil, E.P.E., Porto

  Registry updated 2024-05-23

All Sarcoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error